Dr Reddys Laboratories (RDY) Net Cash Flow (QoQ) (2009 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -157.72% |
| Mar 31, 2026 | -11.83% |
| Dec 31, 2025 | 977.43% |
| Sep 30, 2025 | 112.03% |
| Jun 30, 2025 | 20.84% |
| Mar 31, 2025 | -1,317.97% |
| Dec 31, 2024 | -90.85% |
| Sep 30, 2024 | 388.07% |
| Jun 30, 2024 | -506.37% |
| Mar 31, 2024 | 94.09% |
| Dec 31, 2023 | -195.98% |
| Sep 30, 2023 | 311.83% |
| Jun 30, 2023 | 492.57% |
| Mar 31, 2023 | 84.75% |
| Dec 31, 2022 | -193.43% |
| Sep 30, 2022 | 128.46% |
| Jun 30, 2022 | -13.77% |
| Mar 31, 2022 | -164.53% |
| Dec 31, 2021 | 537.09% |
| Sep 30, 2021 | 127.29% |